StockNews.com assumed coverage on shares of Calithera Biosciences (NASDAQ:CALA – Free Report) in a research note published on Friday morning. The firm issued a hold rating on the biotechnology company’s stock.
Calithera Biosciences Stock Performance
NASDAQ CALA opened at $0.00 on Friday. Calithera Biosciences has a fifty-two week low of $0.00 and a fifty-two week high of $0.12.
Calithera Biosciences Company Profile
Recommended Stories
- Five stocks we like better than Calithera Biosciences
- There Are Different Types of Stock To Invest In
- Analysts Lift Archer Aviation Stock Despite Earnings Miss
- What is a SEC Filing?
- 5 Best Gold ETFs for March to Curb Recession Fears
- The Basics of Support and Resistance
- 3 Stocks for Your Watchlist: Unlocking Tomorrow’s Winners Today
Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
